Introduction {#sec1}
============

Currently, bariatric surgery is the only effective therapy for morbidly obese patients, with sustained weight loss, improvement in comorbidities and positive effects on quality of life after the surgery \[[@cit0001], [@cit0002]\]. Laparoscopic sleeve gastrectomy (LSG) is a safe and effective bariatric operation which has rapidly gained popularity to become the most commonly performed bariatric procedure worldwide \[[@cit0003], [@cit0004]\].

Obesity is considered an important independent risk factor for pelvic floor disorders, including urinary incontinence, faecal incontinence and constipation \[[@cit0005]--[@cit0005]\]. The association between obesity and urinary/faecal incontinence has been clearly documented in the available literature \[[@cit0008], [@cit0009]\]; the prevalence of constipation in obese patients is unclear and reports are often discordant \[[@cit0006], [@cit0010]\].

Bariatric surgery has a significant impact on dietary intake, weight loss, patient's metabolism and also on defaecation stereotypes. However, data regarding changes in bowel habits after bariatric surgery are very limited \[[@cit0007]\]. It has been reported that patients after malabsorptive procedures, such as biliopancreatic diversion (BPD) and Roux-en-Y gastric bypass (RYGB), experience diarrhoea and faecal incontinence more frequently compared to the situation before the operation \[[@cit0011]--[@cit0013]\]. On the other hand, restrictive procedures such as gastric band or LSG may predispose patients to constipation \[[@cit0006], [@cit0012], [@cit0014]\].

Aim {#sec2}
===

To the best of our knowledge, there are only a few studies with very limited numbers of included patients investigating the prevalence and severity of defaecation disorders after LSG. The aim of the present study was to investigate changes in bowel habits of morbidly obese patients after LSG.

Material and methods {#sec3}
====================

Design and setting {#sec3.1}
------------------

This was a prospective observational clinical cohort study designed to evaluate changes in bowel habits of obese patients after LSG. The study was conducted in the University Hospital Ostrava, Czech Republic. All patients with morbid obesity undergoing LSG at the University Hospital Ostrava between 1^st^ January 2012 and 31^st^ December 2017 were assessed for study eligibility. The study was approved by the ethics committee of the University Hospital Ostrava (FNO 339/2018) and was performed in accordance with the ethical standards of the Declaration of Helsinki (1964) and its subsequent amendments. Written informed consent was obtained from all included patients, and anonymity was ensured.

The inclusion criteria were ages 18--65 years, body mass index (BMI) ≥ 40 kg/m^2^ (or BMI 35--39 kg/m^2^ with obesity-related comorbidities) and suitability for elective bariatric surgery. Exclusion criteria were a history of previous surgical procedures on the digestive system, serious neurological or psychiatric diseases, pharmacological treatment that may affect defaecation (e.g. antidepressants, opiates, anticholinergic drugs) and incomplete data regarding patients' follow-up.

Surgical technique {#sec3.2}
------------------

All operations were performed under general anaesthesia; the patient was placed in the supine, anti-Trendelenburg position. The 5-port technique with liver retractor was employed. The omental bursa was opened 4--6 cm proximal to the pylorus, proceeding superiorly to the angle of His, where the left crus was visualised. Gastroepiploic and short gastric vessels were sealed and divided just near the stomach wall. A 36 F orogastric bougie was placed and anchored to the pylorus to avoid stenosis. Green or gold 60 mm cartridges were used to staple and create the final sleeve shape stomach. If small bleeding from the staple line occurred, a bipolar electrocoagulation or clip was used (oversuturing of the staple line was not performed routinely). The resected stomach was removed via a 20 mm port; a drain was then placed along the staple line.

Data collection {#sec3.3}
---------------

All data were collected prospectively during the study. The anamnestic and demographic data of all study patients were recorded in a study database. Prior to surgery, all patients completed two validated questionnaires aimed at evaluating bowel habits -- the Wexner Constipations Score (WCS) and the Cleveland Clinic Incontinence Score (CCIS) \[[@cit0015], [@cit0016]\]. Postoperative complications were graded according to the Clavien-Dindo Classification \[[@cit0017]\]. After the surgery, the standard dietary protocol of study patients consisted of frequent small meals (4--6 meals per day), eating an adequate amount of protein, drinking sufficient amounts of fluids (avoiding carbonated beverages), and separating liquids from solids. Patients had also been advised to eat slowly with proper chewing, and to make an effort to eat a balanced diet and limit consumption of calorie-dense food and drinks \[[@cit0018]\].

Six months after LSG, the patients were invited to a follow-up visit, during which anthropometric parameters and changes in bowel habits were reassessed. The incidence and severity of constipation/faecal incontinence were evaluated by re-administration of the WCS and CCIS questionnaires. The questionnaires were analyzed both for global scores and for selected item sub-scores. We considered abnormal a WCS ≥ 5 and CCIS score ≥ 5. For the purposes of the study, an improvement of the WCS and CCIS greater than 25% was considered clinically relevant.

Statistical analysis {#sec3.4}
--------------------

The acquired data underwent analysis by means of descriptive statistics. The differences between the subgroups were tested using the χ^2^ test, Fisher's exact test and the Kruskal-Wallis rank test. For testing the differences before and 6 months after LSG, paired tests were used (test of symmetry and Wilcoxon signed-rank test). The statistical analysis was conducted using Stata version 15. A level of significance of α = 0.05 was considered statistically significant.

Results {#sec4}
=======

In total, 149 patients underwent LSG at University Hospital Ostrava within the study period. Of these, 25 (16.8%) patients were excluded due to the study design and exclusion criteria ([Figure 1](#f0001){ref-type="fig"}). One hundred twenty-four patients were enrolled in the study and underwent analysis.

![Study flow-chart diagram](WIITM-15-38624-g001){#f0001}

Demographic and clinical data {#sec4.1}
-----------------------------

The mean age of study patients was 47.1 ±11.23 years (mean ± SD); there were 90 (72.6%) women and 34 (27.4%) men. The majority of patients (60.5%) were preoperatively classified as ASA class II. The mean BMI before surgery was 44.3 ±6.83 kg/m^2^. Based on the value of BMI, the patients were divided into three study subgroups ([Table I](#t0001){ref-type="table"}). The mean operative time was 74.2 ±23.63 min; no additional operative procedure (such as cholecystectomy or appendectomy) was performed in our study patients. There were no intraoperative complications; postoperative complications were noted in 8 (6.4%) patients. Out of these, 3 (2.4%) complications were classified as grade I--II according to Clavien-Dindo and 5 (4.0%) complications as grade III--IV. One patient died on the 11^th^ day after LSG because of acute postoperative respiratory failure.

###### 

Demographic and clinical data of study patients

  Parameter                                      BMI \< 40 kg/m^2^ (*n* = 37)   BMI 40--50 kg/m^2^ (*n* = 61)   BMI \> 50 kg/m^2^ (*n* = 26)   Total (*n* = 124)
  ---------------------------------------------- ------------------------------ ------------------------------- ------------------------------ -------------------
  Age, mean ± SD \[years\]                       47.5 ±10.97                    46.8 ±11.64                     47.4 ±11.07                    47.1 ±11.23
  Gender, *n* (%):                                                                                                                             
   Male                                          11 (29.7)                      14 (22.9)                       9 (34.6)                       34 (27.4)
   Female                                        26 (70.3)                      47 (77.1)                       17 (65.4)                      90 (72.6)
  BMI, mean ± SD \[kg/m^2^\]                     37.5 ±1.46                     43.9 ±2.53                      55.0 ±4.82                     44.3 ±6.83
  ASA, *n* (%):                                                                                                                                
   I                                             2 (5.4)                        5 (8.2)                         0 (0.0)                        7 (5.6)
   II                                            24 (64.9)                      40 (65.6)                       11 (42.3)                      75 (60.5)
   III                                           11 (29.7)                      16 (26.2)                       15 (57.7)                      42 (33.9)
  Weight loss, mean ± SD \[kg\]                  23.3 ±7.45                     29.6 ±10.72                     36.5 ±11.85                    29.1 ±11.08
  Percentage excess weight loss (%), mean ± SD   65.1 ±20.25                    55.4 ±19.56                     45.5 ±17.44                    56.2 ±20.42

Weight loss {#sec4.2}
-----------

The mean weight loss 6 months after LSG was 29.1 ±11.08 kg. The differences in weight loss between study subgroups are presented in [Table I](#t0001){ref-type="table"}. The percentage excess weight loss (%EWL -- calculated based on ideal body weight of BMI 25 kg/m^2^) was 56.2 ±20.42% in our study group.

Bowel habits before LSG {#sec4.3}
-----------------------

Before surgery, 46 (37.1%) study patients reported defaecation disorders according to the aforementioned scores (constipation, incontinence or mixed defaecation disorders). As shown in [Table II](#t0002){ref-type="table"}, there were 44 (35.5%) patients who had WCS ≥ 5; only 2 (1.6%) patients reported symptoms of severe constipation (WCS ≥ 15). Symptoms of anal incontinence (CCIS ≥ 5) were found in 8 (6.5%) patients before surgery. Detailed analysis of anal incontinence symptoms (occasional symptoms of anal incontinence for flatus, liquid stools or liquid + solid stools) revealed that almost half of the study patients (43.5%) reported at least occasional incontinence for flatus (gas) before surgery. Mixed defaecation disorders (constipation and incontinence) were found in 6 (4.8%) patients.

###### 

Bowel habits of study patients before surgery

  Parameter                                            BMI \< 40 kg/m^2^ (*n* = 37)   BMI 40--50 kg/m^2^ (*n* = 61)   BMI \> 50 kg/m^2^ (*n* = 26)   *P*-value   Total (*n* = 124)
  ---------------------------------------------------- ------------------------------ ------------------------------- ------------------------------ ----------- -------------------
  Frequency of bowel motion, *n* (%):                                                                                                                            
   1--2 stools per 1--2 days                           25 (67.6)                      42 (68.8)                       20 (76.9)                                  87 (70.2)
   2--3× per week                                      8 (21.6)                       17 (27.9)                       5 (19.2)                       0.551       30 (24.2)
   ≤ 1 per week                                        4 (10.8)                       2 (3.3)                         1 (3.9)                                    7 (5.6)
  Wexner Constipation Score (WCS):                                                                                                                               
   Mean ± SD                                           4.5 ±4.87                      4.1 ±3.65                       3.7 ±2.81                      0.969       4.1 ±3.89
   WCS ≥ 5, *n* (%)                                    13 (35.1)                      20 (32.8)                       11 (42.2)                      0.696       44 (35.5)
  Cleveland Clinic                                                                                                                                               
  Incontinence Score:                                                                                                                                            
   Mean ± SD                                           1.3 ±1.72                      1.7 ±1.78                       1.2 ±1.58                      0.261       1.5 ±1.72
   CCIS ≥ 5, *n* (%)                                   2 (5.4)                        5 (8.2)                         1 (3.8)                        0.802       8 (6.5)
  Occasional symptoms of anal incontinence, *n* (%):                                                                                                             
   Liquid + solid stools                               2 (5.4)                        2 (3.3)                         1 (3.8)                                    5 (4.0)
   Liquid stools                                       1 (2.7)                        12 (19.7)                       4 (15.4)                       0.216       17 (13.7)
   Flatus (gas)                                        18 (48.6)                      27 (44.2)                       9 (34.6)                                   54 (43.5)
  Mixed defaecation                                                                                                                                              
  disorders, *n* (%)                                   2 (5.4)                        3 (4.9)                         1 (3.8)                        1.000       6 (4.8)

Data regarding the correlation between the level of BMI and the prevalence of defaecation disorders are presented in [Table II](#t0002){ref-type="table"}. There were no statistically significant differences in prevalence of defaecation disorders between study subgroups.

Bowel habits after LSG {#sec5.4}
----------------------

The number of patients with normal frequency of bowel motion (1--2 stools per 1--2 days) 6 months after LSG was lower in comparison with preoperative status, but the difference was not statistically significant (59.7% vs. 70.2%, *p* = 0.140). Detailed data regarding changes in bowel habits 6 months after LSG are presented in [Table III](#t0003){ref-type="table"}. The mean postoperative WCS was comparable with preoperative WCS (*p* = 0.900). The number of patients with abnormal WCS (WCS ≥ 5) after LSG was also similar to that of the preoperative status (36.3% vs. 35.5%, *p* = 0.862). Similarly, the mean CCIS score and number of patients with abnormal CCIS after LSG were comparable with preoperative status (the differences were not statistically significant).

###### 

Changes in bowel habits 6 months after LSG

  Parameter                                            Before LSG   6 months after LSG   *P*-value
  ---------------------------------------------------- ------------ -------------------- -----------
  Frequency of bowel motion, *n* (%):                                                    
   1--2 stools per 1--2 days                           87 (70.2)    74 (59.7)            
   2--3× per week                                      30 (24.2)    36 (29.0)            0.140
   ≤ 1 per week                                        7 (5.6)      14 (11.3)            
  Wexner Constipation Score:                                                             
   Mean ± SD                                           4.1 ±3.89    4.2 ±3.77            0.900
   WCS ≥ 5, *n* (%)                                    44 (35.5)    45 (36.3)            0.862
  CCIS:                                                                                  
   Mean ± SD                                           1.5 ±1.72    1.7 ±2.07            0.149
   CCIS ≥ 5, *n* (%)                                   8 (6.5)      11 (8.9)             0.317
  Occasional symptoms of anal incontinence, *n* (%):                                     
   Liquid + solid stools                               5 (4.0)      3 (2.4)              
   Liquid stools                                       17 (13.7)    21 (16.9)            0.760
   Flatus (gas)                                        54 (43.5)    57 (45.9)            
  Mixed defaecation disorders, *n* (%)                 6 (4.8)      7 (5.6)              0.776

Although statistical numbers (percentage, mean ± SD) comparing bowel motion before and after surgery did not show significant differences, detailed analysis of individual patients' symptoms revealed significant changes in bowel habits after LSG (see below).

Out of the subgroup of patients with preoperative constipation (WCS ≥ 5), clinically relevant improvement was noted in 45.5% of patients after the surgery (clinically relevant impairment in 22.7% of patients). Within the subgroup of patients without constipation before surgery (80 patients), impairment was noted in 17 (21.2%) patients after LSG. Symptoms of severe constipation (WCS ≥ 15) were not observed in any of our patients after the surgery.

Out of the subgroup of patients with preoperative incontinence (CCIS ≥ 5), clinically relevant improvement was found in 3 (37.5%) patients; none of these patients reported impairment of incontinence symptoms. Within the subgroup of patients without incontinence before surgery (116 patients), impairment was noted in 6 (5.2%) patients.

Patients with preoperative mixed defaecation disorders reported improvement of constipation and incontinence (2 patients), improvement in constipation (1 patient) or no clinically relevant changes (3 patients).

Discussion {#sec6}
==========

Bariatric surgery presents the most effective form of sustained weight loss in patients with obesity \[[@cit0001], [@cit0003]\]. Despite the significant clinical benefits of bariatric surgery, some patients are disappointed with the weight loss due to unrealistic expectations. Recently, Janik *et al.* proposed a predictive model for estimating BMI at 1 year after LSG. This tool allows one to set realistic expectations of weight loss after LSG. Once a realistic goal is set, the patient can be encouraged to accomplish it \[[@cit0019]\].

Although LSG presents the most commonly performed bariatric procedure worldwide, very little is known about changes in bowel habits of these patients after the surgery. Constipation affects 2--27% of the western population, but the relationship between obesity and constipation is still unclear \[[@cit0020]\]. Some authors reported no association between increasing BMI and constipation prevalence \[[@cit0021]--[@cit0023]\], while other authors found a higher rate of constipation in obese individuals \[[@cit0024], [@cit0025]\]. Our study data confirmed that constipation presents a common problem in obese individuals (37.1% of patients reported symptoms of constipation and reached WCS ≥ 5 before surgery). However, no correlation between rising level of BMI and constipation prevalence/severity was found in our study group.

LSG changes the shape of the stomach, reduces its volume, and alters its vagal innervation and the quantity of secretory cells. Due to different mechanisms (increased gastric emptying and intestinal transit, changes in hormonal mechanisms, alterations in bile acids, etc.), LSG is not considered to be a pure restrictive bariatric procedure \[[@cit0001], [@cit0003]\]. With regards to increased gastric emptying and intestinal transit in patients after LSG, increased prevalence of diarrhoea should be expected. The opposite is true; most available studies suggest increased prevalence of constipation after LSG \[[@cit0012], [@cit0026], [@cit0027]\].

In a retrospective study, El Labban *et al.* compared bowel habits of patients with extreme obesity 1 year after LSG (30 patients) and RYGB (30 patients). In patients after LSG, a significantly higher prevalence of constipation was found \[[@cit0012]\]. Sileri *et al.* investigated the prevalence of defaecatory disorders in 68 morbidly obese patients before and after LSG. The authors reported that the mean WCS score decreased from 3.7 ±3 to 1.6 ±3 and the mean CCIS score decreased from 10 ±8 to 1 ±2 in study patients 6 months after LSG. The authors therefore concluded that bariatric surgery reduces defaecatory disorders, mainly faecal incontinence, and these findings correlate with BMI reduction \[[@cit0006]\].

In a retrospective study consisting of 178 patients after LSG, Goldenshluger *et al*. reported constipation in 24.7% of patients 3 years after the surgery. The evaluation of postoperative defaecation disorders was done only by means of a posted self-constructed questionnaire 3 years after the surgery; prevalence of defaecation disorders before surgery and its changes after LSG were not investigated \[[@cit0028]\].

Our study did not show increased prevalence/severity of postoperative constipation 6 months after LSG. Out of the group of patients with normal bowel habits before surgery, clinically relevant impairment in terms of constipation was noted in 21.2% of patients after the surgery. A very important outcome of our study is that within the subgroup of patients with preoperative symptoms of constipation, clinically relevant improvement was noted in 45.5% of patients postoperatively.

The prevalence of FI in an adult population is estimated from 4% to 19% and is highly dependent on the studied population, definition of incontinence and methods of its detection \[[@cit0029], [@cit0030]\]. Obesity is a known risk factor for the development of FI; epidemiological studies demonstrated almost twofold higher prevalence of FI in obese patients compared to non-obese individuals \[[@cit0031]--[@cit0034]\]. In our study group, a relatively low prevalence of FI preoperatively was recorded (only 6.5% of patients). However, up to 61.3% of our patients reported at least occasional incontinence of flatus or liquid stools.

LSG affected symptoms of incontinence of our study patients very insignificantly -- the prevalence/severity of FI had not changed 6 months after the surgery. However, the number of our study patients with incontinence symptoms before LSG was too low to make any generalizations regarding the impact of LSG on incontinence symptoms. In contract to LSG, it has been reported that malabsorptive bariatric procedures (such as laparoscopic RYGB and BPD) are associated with an increased risk of diarrhoea, flatulence severity and worsening symptoms of faecal incontinence compared to the situation before surgery \[[@cit0011]--[@cit0013]\].

Potoczna *et al.* compared bowel habits of 290 patients at least 4 months after bariatric surgery (BPD, RYGB and AGB). In patients after BPD and RYGB, an increased frequency of loose stools (6.3% vs. 40.5%) and diarrhoea (1.0% vs. 17.5%) was noted after the surgery. Symptoms of constipation were more frequent in patients after AGB (21.3% vs. 39.3%). The authors concluded that the observation period after bariatric surgery had no influence on overall results of bowel habits \[[@cit0011]\].

After malabsorptive bariatric procedures, longer alimentary limbs are associated with severe malabsorption and increased diarrhoea symptoms \[[@cit0035]\]. Restrictive procedures (such as AGB and LSG) do not alter the length and extent of absorption area of the small intestine. The postoperative risk of diarrhoea and associated incontinence is therefore much lower compared to malabsorptive procedures. Our study outcomes suggest that weight loss after LSG does not improve the prevalence/severity of FI. This is in accordance with the available literature, where most studies describe the positive effect of weight loss after bariatric surgery on urinary incontinence but not on faecal incontinence \[[@cit0036], [@cit0037]\]. A recent meta-analysis revealed that more than half of obese patients reported improvement/resolution of urinary incontinence after bariatric surgery. The authors suggested that these data could make bariatric surgery a potentially useful strategy in the management of urinary incontinence in obese patients \[[@cit0038]\].

There is growing evidence suggesting that patients after bariatric surgery not only reduce the volume of food and their caloric intake, but also show changes in food preference \[[@cit0039]\]. Several changes have been described: reduced hunger, reduced preference for calorically dense foods with high sugar and high fat content, change of taste, altered secretion of gut hormones, alterations in the gut microbiota and bile acid levels/composition \[[@cit0039]--[@cit0041]\]. The mechanisms for the food preference changes after LSG may involve both unconditioned and conditioned effects; the decrease in high fat food and sweets suggests that bariatric procedures may influence cognitive choices of food. Changes in eating habits/food preference seem to significantly affect bowel habits of patients after LSG. However, further clinical studies on this topic are needed.

Diet is a key factor influencing the composition and function of the gut microbiota, with rapid alteration seen after short-term diet modification \[[@cit0042], [@cit0043]\]. In patients after LSG, enhanced faecal excretion of bile acids and non-esterified fatty acids has been observed. LSG improves the obesity-associated gut microbiota composition towards a lean microbiome, which plays an important role in nutrient absorption and the regulation of nutrient harvest \[[@cit0043]\]. Postoperative changes in the gut microbiota contribute to weight loss in patients after bariatric surgery and might have an influence on their bowel habits.

It has been demonstrated that LSG leads to weight loss by causing complex alterations in gastrointestinal physiology and changes not only gastric but also global intestinal function \[[@cit0044]\]. LSG significantly accelerates gastric emptying and intestinal motility with markedly reduced intestinal transit time of semisolids \[[@cit0044], [@cit0045]\]. Melissas *et al.* found in their study that although the meal reaches the terminal ileum faster (in patients after LSG), it arrives at the caecum later because caecal filling initiation is delayed \[[@cit0044]\]. The authors suggested that the delay is caused by postoperative changes in the function of the ileocaecal valve. Early and prolonged contact of food with the mucosa of the terminal ileum (earlier food entry and later exit) allows prolonged stimulation of intestinal L cells producing incretins capable of ameliorating glycaemic control. It supports the hypothesis that neuroendocrine changes occurring after LSG alter gastrointestinal function and metabolic profile of the patient. Shortening of gastric emptying time, accelerated small bowel transit and delayed initiation of caecal filling may be important factors significantly influencing bowel habits of patients after LSG. However, further studies are needed to elucidate neuroendocrine changes taking place after LSG.

LSG can be associated with micronutrient deficiencies event if vitamin supplements are included in postsurgical protocols, vitamin D deficiency being the most prevalent long-term nutritional deficiency \[[@cit0046]\]. Thiamine deficiency has been reported in 18% of patients after RYGB and in 25.7% of patients after LSG \[[@cit0047], [@cit0048]\]. According to available data, symptoms of constipation, dyspepsia and vomiting in bariatric patients might be caused by thiamine deficiency. Therefore, when a gastroenterologist sees a bariatric patient with symptoms of constipation, dyspepsia or vomiting, diagnosis of thiamine deficiency should be considered. Early identification and treatment with oral/parenteral thiamine in these patients should be launched \[[@cit0046]--[@cit0048]\].

This was a prospective observational study aimed at investigating changes in bowel habits of obese patients undergoing LSG. The strengths of the study include high homogeneity of the study group, standardized data-acquisition techniques, and precise assessment of bowel habits by means of validated scoring systems used at a fixed time point. To the best of our knowledge, this is the second largest study investigating bowel habits in patients after LSG. The study has several limitations: it was a cohort study with a limited number of patients, and defaecation disorders were examined only once after the surgery.

Conclusions {#sec7}
===========

Our study did not reveal increased prevalence/severity of postoperative constipation or anal incontinence 6 months after LSG. Our findings suggest that weight loss in patients after LSG might be associated with an improvement of constipation symptoms of individual patients. These outcomes potentiate the safety and effectiveness of LSG as primary bariatric surgery.
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